Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
FDA Proposes Expanding Permissible Ingredients in Dietary Supplements
The U.S. Food and Drug Administration announced a proposal to broaden the list of ingredients allowed in dietary supplements, including peptides and certain probiotics. The move, driven by industry pressure, has ignited a clash between manufacturers seeking flexibility and consumer advocates demanding tighter safety safeguards.
Policymaking Needs the Patient Perspective
Colorado Lt. Governor Dianne Primavera, recognized as a HIMSS26 Policy Influencer Changemaker, is championing the integration of patient perspectives into health policy. Drawing on her dual experience as a legislator and a cancer survivor, she advocates for more accessible and...
Trump's Pharma Tariff Won't Lower Prices, Study Finds
Trump's proposed 100% tariff on pharma imports would have limited impact, analysis says. Why? 68% of U.S. prescription drugs are already made domestically. Prices are driven by patents & rebates, not import costs. Healthcare
Wearable Health Devices Expand Clinical Role as FDA Loosens Oversight
The FDA has announced a more flexible oversight approach for low‑risk wearable health devices, effectively lowering regulatory barriers for smartwatches and sensor‑based tools. This shift is accelerating the integration of continuous patient data into both routine and acute clinical care,...
Scaling AI's Promise in Healthcare: The Time Is Now
ZS CEO Pratap Khedkar warns pharma must move from isolated AI pilots to scalable, high‑impact use cases such as clinical trials, commercialization, and supply‑chain intelligence. He cites a new ZS‑Healthcare Leadership Council report showing the sector is transitioning toward targeted...
Study Links Habitual Snoring to Accelerated Heart Aging in 30,000 Users
Researchers publishing in npj Digital Medicine analyzed data from 29,653 adults tracked by Withings devices and found that regular snoring accelerates arterial stiffness—a key marker of cardiac aging—at levels comparable to severe obstructive sleep apnea. The findings challenge the view...
Why “Cleaning” Wipes Are Not Enough: Protecting Patients and Clinicians by Keeping Lead Aprons Truly Clean
Lead aprons, essential radiation shields, are high‑touch items that often harbor dangerous microbes despite routine wipe‑down cleaning. Studies show 84 % of aprons test positive for Staphylococcus aureus and 12 % for MRSA, with biofilms protecting these pathogens from surface disinfectants. Standard...
ARS Pharma Secures FDA Label Expansion for Neffy Needle‑Free Epinephrine Spray
ARS Pharmaceuticals (ticker SPRY) received FDA approval to broaden the label of its Neffy 1 mg needle‑free epinephrine nasal spray, eliminating the previous age restriction and allowing use by anyone weighing at least 33 lb. The change expands market access for the...
Revolution Medicines Initiates P-III (RASolute 303) Trial of Daraxonrasib in Pancreatic Ductal Adenocarcinoma (PDAC)
Revolution Medicines has launched the global Phase III RASolute 303 trial to evaluate daraxonrasib, a direct RAS(ON) multi‑selective inhibitor, in previously untreated metastatic pancreatic ductal adenocarcinoma (PDAC). The study tests the drug as monotherapy and alongside chemotherapy, with progression‑free survival and overall...
Will We Repeat a Deadly Mistake From 100 Years Ago?
A century ago the U.S. government rejected warnings about leaded gasoline, allowing its use for five decades and causing widespread lead poisoning. The resulting health crisis lowered children’s IQ, caused millions of premature deaths, and cost hundreds of billions of...
CMS Finalizes Medicare Advantage Star Ratings Overhaul, Sending Billions of Dollars More to Insurers
The Centers for Medicare & Medicaid Services finalized a rule overhauling Medicare Advantage star ratings, cutting 11 administrative metrics and scrapping the health‑equity index while reinstating a bonus system for high‑scoring plans. The changes shift the rating methodology toward clinical...
The Healthcare Burnout Backlash (Pt 2): Positioning AI Pilots for Success Within EHR-Integrated Environments
Healthcare administrators are grappling with AI pilots that operate alongside, rather than within, electronic health‑record (EHR) systems, creating hidden operational risks. While early pilots can move quickly by using separate data environments, the lack of seamless integration leads to traceability,...
When Silos Hinder Innovation—And When They Can Help
Recent research of 294 studies shows that collective innovation outcomes hinge on how a group is structured, not merely on the amount of collaboration. The authors identify three collective types—convergence‑based, divergence‑based, and attention‑based—defined by search dependence and goal alignment. Real‑world...
Apollo Hospitals Gets NCLT Nod for Corporate Restructuring Plan
Apollo Hospitals Enterprise has secured approval from the National Company Law Tribunal’s Chennai bench for its proposed composite scheme of arrangement, which involves restructuring its digital health, pharmacy and related businesses across four entities. The plan calls for spinning off...
Senators Push to Grill Health Insurance CEOs over Record Profits and Denials
Senators Ron Wyden and Bernie Sanders have asked the Senate Finance and HELP committees to hold hearings with CEOs of major health insurers, citing record profits, high premiums, coverage denials, and excessive executive pay. They point to UnitedHealth’s sprawling network...
Kara Health Builds JV With Loma Linda University Health
Kara Health, a California hospice and palliative‑care provider, has formed a joint venture with Loma Linda University Health to launch Loma Linda University Hospice serving the Inland Empire’s Riverside and San Bernardino counties. Under the agreement, Kara will run day‑to‑day...
The CDC Was Ordered to Prove the DTaP Vaccine Didn't Cause Autism... But Their Only Study Showed It Did
The Institute of Medicine (IOM) concluded in 1991 that evidence was insufficient to determine whether the pertussis (DTaP) vaccine causes autism, a finding reiterated by a 2012 CDC/HRSA review. The only study suggesting a link was excluded for lacking an...
Serenity Medical Receives FDA Humanitarian Device Exemption for IIH Venous Stent
Serenity Medical has secured an FDA Humanitarian Device Exemption for its River venous stent, the first cerebral venous stent cleared for severe, refractory idiopathic intracranial hypertension (IIH). The approval follows the River Study, a multicenter trial of 39 patients that...
What Impact Might Medtronic’s New Lab Have on Galway’s Medtech Ecosystem?
Medtronic has expanded its Galway laboratory by almost 50%, adding state‑of‑the‑art LCMS and GCMS instruments to create a single‑roof hub that blends pharmaceutical, engineering and analytical expertise for combination‑product development. The new facility will handle the full product lifecycle—from early...
FDA Publishes New Set of Real-World Evidence Examples
The U.S. Food and Drug Administration’s Center for Devices and Radiological Health released a new collection of 73 real‑world evidence (RWE) examples that illustrate how medical device marketing authorizations have been supported by real‑world data from fiscal years 2020 through...
Gallbladder Volvulus and the Use of Indocyanine Green
A 65‑year‑old woman with a necrotic gallbladder volvulus underwent laparoscopic cholecystectomy aided by pre‑operative indocyanine green (ICG) fluorescence imaging. ICG enabled real‑time visualization of the common bile duct, necrotic cystic duct, and thrombosed cystic artery, facilitating safe detorsion and confirmation...
The $1.8B Ozempic Middleman and What It Actually Means for Health Tech
Medvi, a two‑person GLP‑1 telehealth brand, posted $401 million in 2025 revenue and is on track for $1.8 billion in 2026, delivering a 16.2% net margin. The company built its consumer‑facing platform using AI tools for under $20,000, while outsourcing all clinical...
7 Science-Backed Strategies to Prevent Recurrent UTIs, According to Doctors
The article outlines seven science‑backed strategies to prevent recurrent urinary tract infections (UTIs) in women, ranging from increased hydration and hygiene to non‑antibiotic medications like methenamine, low‑dose post‑coital antibiotics, vaginal estrogen, cranberry proanthocyanidins, and emerging vaccines. It highlights key risk...
Every “Hassler” Adds ~9 Months to Your Biological Age
Negative relationships may accelerate biological aging. In a new study, each additional “hassler” - someone who often causes problems or makes life difficult - was linked to ~1.5% faster aging and ~9 extra months of biological age. The catch: this showed up...
When Protocols Override Reality: Absurd Medical Billing Errors
You spend years training to make complex clinical decisions, only to spend your days trapped inside a system that refuses to apply basic common sense. We have optimized healthcare for metrics, throughput, and standardized protocols. The goal was to eliminate individual...
VA Teams with Mynd Immersive for Nationwide VR Therapy Rollout
The U.S. Department of Veterans Affairs announced a partnership with Mynd Immersive and Meta to deploy prescriptive virtual‑reality therapy across 45 additional VA medical centers. The expansion builds on earlier pilots and aims to provide scalable, non‑pharmacological treatment for chronic...
Debating Brainless Clones as Personal
Are you pro-bodyoid or anti-bodyoid? For the purpose of this poll, a bodyoid is: a newborn clone of you lacking a cortex, a.k.a. a brainless clone, gestated by a paid surrogate. It's organs are a perfect match (isogenic) to you...
Zero Staff, High Marketing Spend Drives Scalable Revenue
Some are saying this Medvi story is fraudulent. What others in the industry are saying is with zero headcount, all the $ can go into marketing (meta, affiliates, etc). All the infra is rented. Operating margins will be extremely low,...
Henlius Receives the NMPA IND Clearance for HLX319 (Biosimilar, Phesgo)
Henlius has received IND clearance from China’s NMPA for HLX319, a biosimilar of Roche’s Phesgo that combines pertuzumab, trastuzumab and hyaluronidase for subcutaneous delivery. The product targets neoadjuvant, adjuvant and metastatic HER2‑positive breast cancer, mirroring Phesgo’s five‑to‑eight‑minute injection without weight‑based...
Healthcare Gains While Other Sectors Lose Jobs
Over the past year the US economy has added 680,000 healthcare and social assistance jobs and lost 420,000 jobs in all other industries.
Patients Favor Peptides over Statins, Exposing Medical Bias
My patient would rather take a peptide than a statin. That reveals an uncomfortable truth in medicine https://t.co/vCtJj2O6vq via @statnews
Study Finds 240,800 U.S. ER Visits Linked to Cleaning Products for Kids Under 5
Researchers at Nationwide Children’s Hospital identified more than 240,800 emergency department visits for children five and under caused by household cleaning products between 2007 and 2022, an injury every 35 minutes. Detergent packets accounted for a third of cases, while...
Trump Backs Cheaper Drugs, but His Approach Is Corrupt
Trump is right that we should pay less for prescription drugs, but he is trying to lower drug prices in the most corrupt possible way https://t.co/hv87kTzMrg
Imaging Volumes Keep Rising, Revealing Unmet Clinical Demand
Interesting perspective. 👇 Real-world practice suggests the opposite: imaging volumes keep increasing, not decreasing. Although there is certainly a lot of unnecessary imaging performed, the fact that it is still carried out indicates that it fulfills a need beyond appropriateness use...
Proposing Atrial Fibrillation and Heart Failure to Be Manifestations of the Same Condition
Researchers propose that atrial fibrillation and heart failure share a common molecular origin: reduced expression of the transcription factor TBX5. Mouse models lacking TBX5 in the atria develop arrhythmias and gene‑expression patterns that closely resemble heart‑failure signatures. Human atrial tissue...
Hims & Hers Launches Integrated AI‑Driven Digital Health Platform
Hims & Hers Health announced the rollout of an end‑to‑end digital care platform that links AI‑powered diagnosis, telehealth consultations and pharmacy fulfillment. The move comes as insurers tighten coverage for high‑cost drugs and the company grapples with a recent customer‑support...
Is This Healthcare Stock Undervalued Relative to Its Growth Potential?
Oscar Health, a technology‑focused health insurer, has accelerated its ACA marketplace share, reaching 3.4 million members by the end of 2026. The company projects revenue near $19 billion and operating income between $250 million and $450 million, yet its stock trades around $11.92, valuing...
CareSource Acquires Wisconsin Nonprofit Community Care in $155 Million Deal
Ohio‑based health insurer CareSource completed the acquisition of Wisconsin nonprofit Community Care on April 1, agreeing to allocate up to $155 million to a new charitable entity. The deal brings roughly 15,000 Medicaid Family Care members under CareSource’s umbrella and signals accelerating...
CDC Halts Rabies and Pox Virus Testing as Staff Shortages Cut Workforce by Up to 25%
The U.S. Centers for Disease Control and Prevention has temporarily stopped rabies and pox virus testing because severe staffing shortages have left the rabies unit with a single specialist and the pox unit without any experts. The pause affects more...
Headline Vs. Study, Economics Edition
A JAMA research letter examined the CMS BALANCE model, estimating that treating 550,000 to 3.6 million Medicare beneficiaries with semaglutide could generate savings sufficient to offset program costs. The study presented a range of possible budget outcomes and concluded that additional...
Why ‘Boring’ AI Could Save Healthcare When the Bubble Bursts
The healthcare AI market is facing a sharp correction, with Series B funding dropping 84% from its 2021 peak and 95% of enterprise pilots failing to show ROI. Most failures stem from demo‑centric tools that cannot survive fragmented clinical data environments....
Prediabetes May Need a Tailored Treatment Rethink
Researchers presented new data on 662 U.S. adults aged 18‑40 with prediabetes, revealing that the average five‑year risk of progressing to type 2 diabetes is 7.5%. The risk climbs to 10.9% for those meeting GLP‑1 receptor agonist (GLP‑1RA) weight‑loss criteria, 15.1%...
Walk-In Lab Testing Expands Patient Access and Autonomy in West Virginia
Walk‑in laboratory services are rapidly expanding in West Virginia, allowing patients to purchase routine diagnostic tests without a physician referral. Facilities such as Any Lab Test Now and hospital outreach centers provide transparent, upfront pricing and deliver results through secure...
Food As Medicine: From Trend to Treatment W/ Spencer Pratt, Chief Growth Officer, NourishedRx
In this episode of CareTalk, John Driscoll speaks with Spencer Pratt, Chief Growth Officer of NourishedRx, about the company’s digital health platform that uses clinically‑guided food delivery, tele‑nutrition counseling, and digital coaching to treat diet‑related chronic diseases. Pratt explains how...
Well Health Partners with AliveCor for Cardiologist Review
Well Health has teamed with AliveCor to embed Canadian‑registered cardiologists into the Kardia app’s AI‑driven ECG workflow. Canadian users can now request a Clinician Review, receiving a written physician interpretation within 24 hours. The service leverages Health Canada‑cleared AI algorithms...
Annovis Wins US Patent for Buntanetap in Brain Infection Injuries
Annovis Bio has been granted a United States patent for its compound Buntanetap, specifically covering its use in treating brain infection‑related injuries. The patent expands the drug's previously explored Alzheimer’s indication to a novel therapeutic area. This intellectual‑property win bolsters...
Medline: A Lack Of Compelling Risk-Reward Makes Me Cautious
Medline posted strong Q4 momentum and 2025 sales growth, but margin pressure kept profits largely flat. The company projects 8‑9% organic sales growth and modest adjusted EBITDA improvement in 2026, yet margin compression and leverage remain concerns. Recent sales by...
Multipurpose Anti-Viral Pill May Treat Colds, Norovirus, Flu and Covid
Artificial intelligence flagged a long‑neglected breast‑cancer medication as a candidate to block multiple viruses, and subsequent animal studies confirmed it can inhibit coronaviruses, RSV, norovirus, influenza and hepatitis viruses. Model Medicines, a California biotech, is advancing the compound toward a...
Listen: What the Vaccine Schedule Whiplash Means for Your Kids
A federal judge has blocked the Trump administration’s effort to adopt a shortened childhood vaccine schedule championed by Health and Human Services Secretary Robert F. Kennedy Jr. The decision, likely to be appealed, leaves the nation in a policy limbo...
Maui Mental Health Providers Face Stress and Uncertainty About State Jobs
Hawaii’s Department of Health extended the contracts of Maui’s state‑run mental‑health clinic staff for six months, leaving many counselors and caseworkers uncertain about permanent state positions. The extension arrived without clear stipulations, prompting part‑time providers like psychologist Nancy Sidun to...